National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting, 24892 [2011-10672]
Download as PDF
srobinson on DSKHWCL6B1PROD with NOTICES
24892
Federal Register / Vol. 76, No. 85 / Tuesday, May 3, 2011 / Notices
Skeletal Muscle and Exercise Physiology
Study Section.
Date: June 9–10, 2011.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Loews Annapolis Hotel, 126 West
Street, Annapolis, MD 21401.
Contact Person: Richard Ingraham, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7814, Bethesda, MD 20892, 301–496–
8551, ingrahamrh@mail.nih.gov.
Name of Committee: Immunology
Integrated Review Group, Cellular and
Molecular Immunology—A Study Section.
Date: June 9–10, 2011.
Time: 9 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Admiral Fell Inn, 888 South
Broadway, Baltimore, MD 21231.
Contact Person: David B. Winter, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4204,
MSC 7812, Bethesda, MD 20892, 301–435–
1152, dwinter@mail.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group, Biobehavioral Regulation, Learning
and Ethology Study Section.
Date: June 9, 2011.
Time: 9 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Carlyle Suites Hotel, 1731 New
Hampshire Avenue, NW., Washington, DC
20009.
Contact Person: Melissa Gerald, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3172,
MSC 7848, Bethesda, MD 20892, (301) 408–
9107, geraldmel@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, BTSS and
SAT Member Conflict.
Date: June 9, 2011.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Guo Feng Xu, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5122,
MSC 7854, Bethesda, MD 20892, 301–237–
9870, xuguofen@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Prokaryotic
Biology.
Date: June 9, 2011.
Time: 6 p.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street,
NW., Washington, DC 20036.
Contact Person: Diane L. Stassi, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2200,
VerDate Mar<15>2010
20:39 May 02, 2011
Jkt 223001
MSC 7890, Bethesda, MD 20892, 301–435–
2514, stassid@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 26, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–10675 Filed 5–2–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases, Special Emphasis Panel, Clinical
Trial Pilot Grant Review.
Date: May 12, 2011.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Charles N. Rafferty, PhD,
Chief, Scientific Review Branch, National
Institute of Arthritis, Musculoskeletal and
Skin Diseases, National Institutes of Health,
6701 Democracy Boulevard, Suite 800,
Bethesda, MD 20817, 301–594–5019,
charles.rafferty@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Closed
Meeting
Notice is hereby given of a meeting of
the Advisory Committee to the Director,
National Institutes of Health (NIH),
Orientation Work Group. The meeting
will be closed to the public.
The NIH Director’s Pioneer Award
and New Innovator Award programs are
part of the NIH Common Fund and
support exceptionally creative scientists
who take highly innovative, potentially
high-impact approaches to major
challenges in biomedical or behavioral
research. The members of the Advisory
Committee to the Director, NIH will be
participating in an orientation work
group meeting for the purpose of
receiving instructions on their role and
responsibility in the review of these
applications requesting NIH research
support. Members will be participating
in the final review of both the NIH
Director’s Pioneer Award and New
Innovator Award grant reviews during
the June 9–10, 2011 meeting of the
Advisory Committee to the Director,
NIH.
The Orientation Work Group
discussions could disclose confidential
trade secrets or commercial property
such as patentable materials, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Work Group: Advisory Committee
to the Director, NIH, Orientation Work
Group.
Date: May 26, 2011.
Closed: 3 p.m. to 4 p.m.
Agenda: To receive instruction and
guidance for the review of the NIH Director’s
Pioneer Award and New Innovator Award
programs.
Place: National Institutes of Health,
Building 1, Room 103, One Center Drive,
Bethesda, MD 20892, (Teleconference).
Contact Person: Gretchen S. Wood, Special
Assistant to the Associate Director for OD
Coordination, Immediate Office of the
Director, National Institutes of Health, One
Center Drive, Building 1, Room 103,
Bethesda, MD 20892, woodgs@od.nih.gov.
Dated: April 22, 2011.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
Dated: April 26, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–10672 Filed 5–2–11; 8:45 am]
[FR Doc. 2011–10667 Filed 5–2–11; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
PO 00000
Frm 00045
Fmt 4703
Sfmt 9990
E:\FR\FM\03MYN1.SGM
03MYN1
Agencies
[Federal Register Volume 76, Number 85 (Tuesday, May 3, 2011)]
[Notices]
[Page 24892]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-10672]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, Special Emphasis Panel, Clinical
Trial Pilot Grant Review.
Date: May 12, 2011.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, 6701
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Charles N. Rafferty, PhD, Chief, Scientific
Review Branch, National Institute of Arthritis, Musculoskeletal and
Skin Diseases, National Institutes of Health, 6701 Democracy
Boulevard, Suite 800, Bethesda, MD 20817, 301-594-5019,
charles.rafferty@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: April 22, 2011.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-10672 Filed 5-2-11; 8:45 am]
BILLING CODE 4140-01-P